Let's talk medical research

Updated in December 2021

During the COVID-19 pandemic, many clinical trials adapted by adding virtual elements to their traditional trial approaches. While many could not go fully virtual due to the need to collect samples at specific milestones and check on patients in person, folding in technology kept patients safer and reduced the burden to participation. In many cases, it allowed research to stay on track while the ...

Nonalcoholic steatohepatitis, also known as NASH, is an aggressive, severe form of nonalcoholic fatty liver disease (NAFLD). When NASH progresses, it can cause liver inflammation, fibrosis, cirrhosis, and eventually liver failure or cancer.

Clinical trial patient recruitment companies work with sponsors and study teams to identify opportunities and challenges for recruiting and retaining patients, and then implement a strategy to find patients for particular trials.

For people living with hemophilia, a chronic condition in which blood doesn’t clot normally, treatment options are limited and the threat of internal bleeding can be very serious. That’s why research that’s currently underway to identify new and better ways to manage the condition is so important, and why we were excited to support a recent project to push hemophilia research forward.

Diversity, equity, and inclusion (DEI) is a hot topic in clinical research — and for good reason. If medications aren’t tested on populations that reflect the real world, how will we know what works best for all patients? In order to understand the importance of this issue, and recognize progress when it comes, we’ve put together a one-pager that provides a snapshot of the current state of ...

November is both National Alzheimer’s Disease Awareness Month and National Family Caregiver Month, a time to show support for the millions of people who are living with Alzheimer’s disease and to honor the invaluable family members and friends serving as Alzheimer’s caregivers. Stacy Pagos Haller, President and CEO of the BrightFocus Foundation, talked to us about why recognizing Alzheimer’s ...

Our partner, the College Diabetes Network (CDN), is a national organization serving thousands of Type 1 Diabetes (T1D) students, their families, and their support networks. We spoke with the CDN to learn more about how they got their start, what they’ve been doing to help the T1D community throughout the COVID-19 pandemic, where they come up with relatable blog content, and why T1D clinical ...

One alternative clinical trial approach that has gained steam due to the COVID-19 pandemic is the decentralized study, which makes it possible for research to be done virtually. Our infographic below sums up seven advantages and three key weaknesses of decentralized trials:

November is Lung Cancer Awareness Month (LCAM), an important time of year for the lung cancer community to unite to raise awareness, educate, and spread hope. We spoke with Andrew Ciupek, PhD, Senior Manager, Clinical Research; Rashmi Acharya, MS, Specialist, Science and Research; and Daniel Saez, MSc, Treatment and Trials Navigator – members of the LungMATCH Navigation Team at the GO2 Foundation ...